Quantitative analysis of prenylated RhoA interaction with its chaperone, RhoGDI by Tnimov, Zakir et al.
Quantitative Analysis of Prenylated RhoA Interaction with Its
Chaperone, RhoGDI*□S
Received for publication,April 10, 2012 Published, JBC Papers in Press,May 24, 2012, DOI 10.1074/jbc.M112.371294
Zakir Tnimov‡, Zhong Guo‡, Yann Gambin‡, Uyen T. T. Nguyen§, Yao-WenWu§, Daniel Abankwa¶, Anouk Stigter,
Brett M. Collins‡, Herbert Waldmann, Roger S. Goody§, and Kirill Alexandrov‡1
From the ‡Department of Molecular Cell Biology, Institute for Molecular Bioscience, The University of Queensland,
306 Carmody Road, St. Lucia, Queensland 4072, Australia, the Departments of §Physical Biochemistry and Chemical Biology,
Max-Planck-Institute for Molecular Physiology, Otto-Hahn-Str. 11, 44227 Dortmund, Germany, and the ¶Turku Centre for
Biotechnology, University of Turku and Abo Akademi University, BioCity, Tykistokatu 6BFIN-20520 Turku, Finland
Background: RhoGDI is a key regulator and a chaperon of Rho GTPases.
Results: RhoGDI strongly discriminates between GDP- and GTP-bound forms of prenylated RhoA, although both complexes
are of high affinity.
Conclusion: We provide direct evidence for the existence of two populations of the RhoGDIRhoA complexes in the cell,
characterized by different lifetimes.
Significance: The obtained data allows us to formulate the model for membrane delivery and extraction of Rho GTPases.
Small GTPases of the Rho family regulate cytoskeleton
remodeling, cell polarity, and transcription, as well as the cell
cycle, in eukaryotic cells. Membrane delivery and recycling of
theRhoGTPases ismediated byRhoGDPdissociation inhibitor
(RhoGDI), which forms a stable complex with prenylated Rho
GTPases. We analyzed the interaction of RhoGDI with the
active and inactive forms of prenylated and unprenylated
RhoA. We demonstrate that RhoGDI binds the prenylated
form of RhoAGDP with unexpectedly high affinity (Kd  5
pM). The very long half-life of the complex is reduced 25-fold
on RhoA activation, with a concomitant reduction in affinity
(Kd  3 nM). The 2.8-A˚ structure of the RhoAguanosine
5-[,-imido] triphosphate (GMPPNP)RhoGDI complex
demonstrated that complex formation forces the activated
RhoA into a GDP-bound conformation in the absence of
nucleotide hydrolysis. We demonstrate that membrane
extraction of Rho GTPase by RhoGDI is a thermodynamically
favored passive process that operates through a series of pro-
gressively tighter intermediates, much like the one that is
mediated by RabGDI.
The Rho family of GTPases plays important roles in a
plethora of cellular functions. The defining members of this
family, RhoA, Rac1, and Cdc42, regulate cytoskeleton
remodeling, cell polarity (1, 2), and transcription (3), as well
as the cell cycle (4). Similar to other Ras family GTPases, the
Rho proteins cycle between the inactive GDP-bound and the
active GTP-bound effector binding competent states. This
cycle is tightly controlled by guanine nucleotide exchange fac-
tors (GEFs)2 that facilitate loading Rhowith guanosine triphos-
phate (5) and GTPase-activating proteins that dramatically
accelerate the intrinsic rate of GTP hydrolysis (6).
Similar to the majority of other Ras superfamily members,
the Rho proteins are posttranslationally prenylated on their C
termini. RhoGTPases are predominantly singly geranylgerany-
lated, although farnesylation has also been reported (7). These
modifications enable small GTPases to reversibly and dynami-
cally associate with intracellular membranes. In a number of
cases,membrane deliverywas shown to be functionally coupled
to GTPase activation. For instance, GTP loading of the Arf
GTPases exposes their otherwise buried myristoylated N-ter-
minal helix and promotes association of Arf proteins with the
plasma membrane (8). Similarly, GEF-mediated loading of Rab
GTPases with GTP reduces its affinity for its chaperone, Rab
GDP dissociation inhibitor (RabGDI), by 3 orders ofmagnitude
and promotes association of GTP-bound RabGTPases with
their target membrane (9).
As in the case of Rab proteins, membrane/cytosol cycling of
geranylgeranylated Rho GTPases is regulated by functionally
similar but structurally unrelated GDP dissociation inhibitors
(RhoGDIs). In contrast to the RabGDI, RhoGDIs were reported
to interact with both GDP- and GTP-bound Rho proteins with
similar efficiency (10–13).However, the exact affinities of these
interactions are still disputed (14–16).
The lack of clear evidence for the role of nucleotide exchange
in the dissociation of RhoRhoGDI complexes has led to a
search for alternative mechanisms of the membrane recruit-
ment of Rho. A number of putative GDI displacement factors
were proposed to promote dissociation of the RhoGDIRho* This work was supported in part by Australian Research Council DP Grant
DP1094080, ARC FFGrant FT0991611, andNational Health ResearchCoun-
cil project Grant 569652 (to K. A.).
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complexes in vivo. These include receptors, such as p75 NTR
(17) and integrins (18), and associated proteins, such as ERM
(19) and merlin (20). However, no thermodynamically sound
model has been proposed that would explain how GDI dis-
placement factors could reduce the high affinity of the
RhoGDI/Rho interaction. One alternative explanation is that
these molecules act as scaffold proteins that recruit RhoGEFs
(21–23) and membrane phosphoinositides (21), which have
been proposed to facilitate RhoRhoGDI complex dissociation
(22). Phosphorylation of RhoGDI or Rho proteins was also
shown to influence the Rho/RhoGDI interaction, strongly
affecting their association in the cell (23–27). Phosphorylation
of Rho GTPases is believed to promote their extraction from
the membranes by RhoGDI, whereas phosphorylation of
RhoGDI diminishes its ability to bind Rho.
Despite numerous reports on the possible mechanisms that
govern membrane delivery and recycling of Rho GTPases, a
kinetic and thermodynamic description of such mechanisms is
still outstanding. Therefore, this study reports on the quantita-
tive biophysical analysis of RhoA interactionwith RhoGDIwith
the objective of determining the kinetic and thermodynamic
framework of the Rho functional cycle. In contrast to previous
findings, we have demonstrated that RhoGDI discriminates
strongly between different nucleotide-bound forms of preny-
lated and unprenylated RhoA. We provide direct evidence for
the existence of two populations of the RhoGDIRhoA complex
in the cell, characterized by different lifetimes.We also propose
a thermodynamic model of RhoGDI-mediated RhoGTPase
recycling.
MATERIALS ANDMETHODS
Protein Expression and Purification—All proteins used in
this study were expressed in the Escherichia coli BL21(DE3)
CodonplusRIL strain (Stratagene). Expression and purification
of FTase, GGTase-I, and RhoAF25N were carried out as
described previously (28). RhoGDI was cloned in-frame with
maltose-binding protein using the pOPINM vector (29),
expressed in E. coli, and purified by nickel-nitrilotriacetic acid
chromatography. The tag was removed by proteolysis with Pre-
cision protease, and the protein was further purified by gel fil-
tration on a Superdex 200 26/60 column (GE Healthcare). The
L193Amutant of RhoAF25N was constructed by PCRmutagen-
esis of the pGATEV-RhoAF25N plasmid using the forward
5-GATGGGTATCCATGGCTGATG-3, and reverse primer
5-GGATCCCTCGAGTCATGCGACAAGGC-3, and sub-
cloning the resulting PCR product into the NcoI and XhoI sites
of the pGATEV vector (30). The C-terminal citrine-RhoGDI
was cloned using the in-fusion protocol into the pOPINE vector
(29). The CFP N-terminal fusion of RhoA was cloned into the
pGATEV vector using the forward 5-CATCACAACACTAG-
TATGGTGAGCAAGGGCGAGGAGCTG-3, and reverse 5-
ATTCTCATCAGCC-ATGGACTTGTACAGCTCGTCCAT-
GCCG-3, primers and cloning of the PCR fragment into SpeI
and NcoI sites.
Preparation of GMPPNP-, mantGDP-, and mantGMPPNP-
bound forms of the RhoA—Nucleotide exchange on the RhoA
molecule was performed as described earlier (31).
Enzymatic Prenylation of the RhoA—Purified RhoA was
enzymatically prenylated in vitro by GGTase-I using gera-
nylgeranyl or NBD-geranyl pyrophosphates as substrates.
RhoAL193A was farnesylated by FTase using FPP as a substrate.
The prenylation reaction was carried out in 2–4 ml of prenyla-
tion buffer containing 25 mM Hepes-NaOH, pH 7.2, 40 mM
NaCl, 2mMMgCl2, 2mM dithioerythritol, 20MGDP or 20M
GMPPNP, and 20 M ZnCl2. A typical reaction contained 60
nmol of the prenyltransferase, mixed with 2-fold excess of
RhoA and 260 nmol ofGGPP (Sigma) or 550 nmol ofNDB-GPP
(28). The RhoA farnesylation reaction contained 10 nmol of
FTase, 100 nmol of RhoA, and 400 nmol of FPP (Sigma).
After incubation for 4 h at room temperature, the reaction
mixture was chromatographed on a Superdex 200 10/30 gel
filtration column (GE Healthcare) equilibrated with prenyla-
tion buffer without ZnCl2. The flow rate was 0.35 ml/min, and
fractions of 0.3 ml were collected and analyzed by 15% SDS-
PAGE.When the fluorescent analogwas used as a substrate, the
gel was scanned using a Typhoon Trio fluorescent scanner (GE
Healthcare) (excitation 488 nm; cutoff filter 520 nm), and the
gel was subsequently stained with Coomassie Blue. Isoprenoid
conjugation was confirmed by electrospray ionization-mass
spectrometry of the selected fractions. The eluted fractions
containing the protein complex were combined, concentrated,
flash-frozen in liquid nitrogen, and stored at80 °C.
The complex of geranylgeranylated RhoA andGGTase-I was
obtained by size exclusion chromatography on a Superdex 200
column of the in vitro prenylation reaction containing equimo-
lar amounts of GGTase-I and RhoA. The fractions containing
the protein complex were collected, concentrated to 10mg/ml,
and stored as described above.
Labeling of the RhoGDI with Maleimide Dyes—The tetra-
methylrhodamine-maleimide dye was obtained from Molecu-
lar Probes, and RhoGDI labeling was performed according to
the manufacturer’s protocol. The degree of labeling, based on
spectroscopic observation, was typically 50%.
Fluorescence Measurements—Fluorescence spectra and long-
time base fluorescence measurements were performed at 25 °C
in 1-ml quartz cuvettes (Hellma, Germany) with continuous
stirring on a Spex Fluoromax-3 or Fluoromax-4 spectrofluo-
rometer (Jobin Yvon Inc., USA). Fluorescence titrations were
carried out in buffer containing 25 mM Hepes-NaOH, pH 7.2,
40 mM NaCl, 2 mM MgCl2, 5 mM dithioerythritol, and 20 M
guanosine nucleotide (GDP or GMPPNP). NBD-Geranyl was
excited at 479 nm (slit 4 nm), and the emission was monitored
at 560 nm (slit 8 nm). The dissociation of the fluorescent CFP-
RhoA-GGRhoGDI-citrine complex was monitored with
extinction at 436 nm (4 nm slits), and emission spectra at 475–
530 nm were read. The FRET efficiency (EFRET) was defined as
intensity of the citrine (acceptor, 530 nm) divided by the sum of
the intensity of the CFP (donor, 475 nm) and acceptor.
EFRET
ICitrine
ICitrine ICFP
(Eq. 1)
Primary data analysis was performed with the programs Grafit
5.0 (Erithacus software) and “fluorescence” implementation
(Jobin Yvon Inc., USA) of Origin 7.0 (Originlab Corp., USA).
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Fluorescence Cross-correlation Measurements—Measure-
ments were done on an inverted laser scanning confocal micro-
scope Zeiss LSM 710 FCS, equipped with a Confocor 3 module
(FCCS detector head and APD detectors). Normally, the exci-
tation laser beams were focused on 20 l of the sample, placed
on the well of an in-house made silicon plate mounted on an
optically clear coverslip. Emitted light from the 458-nm and
561-nm lasers passed through an adjustable pinhole and a 458/
561 main beam splitter and was separated on a 565-nm dia-
chronic mirror. The 470–540-nm spectra segment was used to
quantify fluorescence from CFP, whereas a long pass 580-nm
filter was set for measuring the tetramethylrhodamine dye sig-
nal. The laser power was set up to achieve a count rate (CPM)
that was not giving detectable cross-talk. Typically, CPM was
kept at 8 to 12 kHz. The data acquisition time was at least 100 s
and included 10 runs of 10 s each. The collected data were
analyzed using the ZEN 2011 Zeiss software package. The the-
oretical basics of autocorrelation and cross-correlation analysis
are described everywhere (32). Experimental autocorrelation
functions were fitted in a three-dimensional diffusion model
(33) for a 2-component model. The Kd for the interaction of
geranylgeranylated CFP-RhoA and tetramethylrhodamine-la-
beled RhoGDI (RhoGDI-TMR) was quantified based on the
assumption that the amplitude of the cross-correlation func-
tion (CCF) corresponds linearly to the concentration of the
CFP-RhoA-GGRhoGDI-TMR complex. The CCF values
obtained by titration of the 50 nM CFP-RhoA-GGRhoGDI-
TMR solutionwith farnesylatedRhoAwere fitted to the 3-com-
ponent competitive model in Dynafit 4.0 (Biokin Ltd.) (34).
Analysis of Titrations of NBD-geranylated RhoA Versus
Increasing Concentration of RhoGDI or GGTase-I—Titrations
were fitted to the explicit solution of the quadratic equation
describing the P  L N PL binding equilibrium, where Kd is
defined as Kd  [P][L]/[PL]. For titrations performed in this
study, the concentration of RhoA-geranyl-NBD (RhoA-GNBD)
was fixed [P0], and increasing concentrations of GGTase-I or
RhoGDI [L0] were added. Total concentrations of [P0] and [L0]
are the sum of free and bound species. Under these conditions,
the fluorescence is described as,
F  Fmin

Fmax FminP0 L0 Kd P0 L0 Kd 4P0L0
2P0
(Eq. 2)
where F is the measured fluorescence intensity and Fmax and
Fmin refer to the maximal and minimal of its value. The param-
eters [P0], Fmax, Fmin, andKdwere allowed to vary during the fit.
The nonlinear least-square regression was performed in Grafit
5.0 (Erithacus software).
Global Fitting Analysis of Competitive Titrations—Compet-
itive titrationwas performed by titrating themixture of fluores-
cent RhoA-GNBD and prenylated RhoAGGTase-I complex
with increasing concentrations of RhoGDI. The global fitting
procedure of the obtained data were performed in Dynafit 4.0
(Biokin Ltd.) (34).
Stopped-flowMeasurements—The kinetics of the prenylated
RhoA interaction with RhoGDI was analyzed using an
SF-61MX stopped flow apparatus (High Tech Scientific).
Measurementswere carried out at 25 °C in degassed buffer con-
taining 25mMHepes-NaOH, pH7.2, 40mMNaCl, 2mMMgCl2,
and 5 mM dithioerythritol. Fluorescence of the NBD group was
excited at 479 nm, and the data were collected with a 515-nm
cut-off filter. Transient kinetics of the RhoGDI interactionwith
RhoA bound to mant-labeled guanine nucleotides was mea-
sured under the same conditions, except that fluorescence of
the mant group was excited via FRET from tryptophan at 289
nm and detected through a 395-nm cut-off filter. To improve
the signal to noise ratio, data from 5 to 10 measurements were
averaged and used for further analysis. Data collection and pri-
mary analysis of the rate constants were performed with the
High Tech Scientific package, and the secondary analysis was
performed using Grafit 5.0 (Erithacus software).
Isothermal Titration Calorimetry Measurements—Binding
affinities of the unprenylated GDP- and GMPPNP-bound
forms of RhoA to RhoGDI were determined using ITC200
(MicroCal). All proteins were kept in buffer containing 25 mM
Hepes-NaOH, pH 7.2, 40 mM NaCl, 2 mM MgCl2, and 1 mM
DTT. The concentration of RhoA protein in the syringe was at
least 10-fold higher than the concentration of protein in the cell
(typically 10M). In control experiments, the respective protein
was injected from the syringe into the buffer solution, and
the recorded background signals were subtracted from the
titration experiment data. The titration experiments were
carried out at 25 °C in triplicate. The data obtained were
fitted using the MicroCal-ITC implementation of the Origin
7 software package.
Crystallization of RhoAGMPPNP-GGRhoGDI Complex,
Data Collection and Structure Determination—Initial crystalli-
zation conditions were determined at room temperature using
the PEG Ion kit fromHamptonResearch in 200-nl sitting drops,
set up against a 50-l reservoir with a Mosquito nanoliter dis-
pensing robot (TTPLabTech). Promising conditionswere opti-
mized with respect to precipitant composition, pH, tempera-
ture, and protein concentration and were transferred to
hanging drops prepared by mixing 1 l of protein complex
solution with 1 l of precipitant mixture. Crystals for data col-
lectionwere obtained at 20 °Cwith a reservoir consisting of 20%
(w/v) PEG 3350, 0.2 M MgCl2, and 0.1 M Hepes-NaOH, pH 7.4.
The protein complexwas used at 13mg/ml in buffer containing
25mMHepes-NaOH, pH 7.2, 40 mMNaCl, 2 mMMgCl2, 10M
GMPPNP, and 1 mM Tris(2-carboxyethyl)phosphine.
Prior to flash-cooling in liquid nitrogen, the crystals were
washed briefly in 25% (w/v) PEG 3350, 5% (v/v) glycerol, 0.2 M
MgCl2, and 0.1 MHepes, pH 7.4. Diffraction data were collected
at 100 K at station MX2 of the Australia Synchrotron (Mel-
bourne, Australia). The data were processed with XDS (55).
The crystals belonged to the orthorhombic space group
P212121 and contained 1 RhoA-GGRhoGDI complex in the
asymmetric unit.
Initial phases were determined by molecular replacement
with PHASER (56) of the CCP4 suite, using coordinates of
Cdc42GDP-GGRhoGDI (PDB code 1DOA) from which the
nucleotide, Mg2, and prenylated C terminus of Cdc24 had
been deleted. The model was then corrected by alternating
rounds of refinement in REFMAC5 (57) and manual adjust-
ment in COOT (58). Restraint libraries were generated with
Quantitative Analysis of RhoA Interaction with RhoGDI
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PRODRG (59). Interface analysis was performed with PISA at
the EBI website (35). Structure figures were generated using
PyMOL.
RESULTS
Interaction Analysis of RhoGDI with Unprenylated RhoA—
To gain insight into the mechanism of the interaction of
RhoGDI with RhoA GTPase and the role of the nucleotide-
bound state in this process, we assessed the thermodynamics of
this interaction. We measured the affinity of the interaction
betweenRhoGDI and recombinant unprenylated RhoA, loaded
with GDP- or the unhydrolyzable GTP analog GMPPNP, using
isothermal titration calorimetry (ITC). We found that RhoGDI
forms a complex with GDP- and GMPPNP-bound RhoA with
Kd values of 0.17 and 2.5 M, respectively (Fig. 1, A and B). To
confirm the obtained affinity values using an independent
method,wedecided tocharacterize thekineticsof this interaction.
We loaded RhoA molecules with the fluorescent nucleotide
mant-GDP or mant-GMPPNP, a nonhydrolyzable fluorescent
analog of GTP. Rapid mixing of the mant nucleotide-loaded
RhoA with RhoGDI in a stopped-flow apparatus resulted in
time-dependent fluorescence signal changes. The plots in Fig.
1, C and E, represent a typical fit to the experimental data. The
insets show the dependence of the pseudo-first order rate con-
stants on the concentration of RhoGDI. Although the data give
a good estimate of the kon values, the koff cannot be extracted
from the intercept with y axis reliably, due to its low value in the
case of GDP-bound RhoA and low signal amplitudes in the case
of the GMPPNP-bound form. Therefore, we determined koff
values experimentally by displacing mant nucleotide-labeled
RhoA from RhoARhoGDI complexes with an excess of nonla-
beledGDP-boundRhoA (Fig. 1,D andF). Analysis of the kinetic
parameters of the RhoGDI interaction with both nucleotide-
bound forms of RhoA (Table 1) shows that the affinity dif-
ferences stem from a 15-fold faster off-rate of the RhoGDI
complex with the activated RhoA. The affinities that were
calculated from the kinetic constants were 0.2 M for GDP-
bound and 2.3 M for GMPPNP-bound RhoA and are in
good agreement with the Kd values obtained in the ITC
measurements.
To assess the role of the RhoA C terminus in RhoGDIRho
complex assembly, we prepared C-terminal truncated 	9 and
	13RhoAmutants that lacked theC-terminal stretch lysines or
in addition arginine residues, respectively (Fig. 2A). Interaction
of the truncationmutants with RhoGDI was assessed by ITC as
described for the wild-type protein. The titration experiments
showed that deletion of 9 C-terminal residues led to a 15-fold
decrease in the affinity of the RhoA/RhoGDI interaction (Fig. 2,
B and C). Further deletion of C-terminal residues did not sig-
FIGURE 1. Interaction analysis of RhoGDI with unprenylated RhoA. A, representative ITC data for titration of 10 M RhoGDI with either 160 M RhoAGDP
(filled squares) or buffer (open squares). Solid curve represents a fit of the data to a 1:1 stoichiometry bindingmodel with a calculated Kd value 213 nM; B as in A
except that RhoGDI was titratedwith 130M RhoAGMPPNP (filled squares) or buffer (open squares). The fit resulted in a Kd value of 5.7M. C, kinetic analysis of
the RhoGDI interaction with unprenylated RhoAmGDP. A typical fluorescence change observed uponmixing 0.4M RhoAmGDPwith 8M RhoGDI. The inset
represents a plot of the observed rates as function of RhoGDI concentration.D, fluorescence change uponmixing of 0.4MRhoAmGDPRhoGDI complexwith
5 M RhoAGDP. E, fluorescence change resulting frommixing of 0.4 M RhoAmGMPPNP with 12 M RhoGDI. The inset represents the plot of observed rates
as a function of RhoGDI concentration. F, fluorescence change upon mixing of 1.2 M RhoAmGMPPNPRhoGDI with 20 M RhoAGMPPNP.
TABLE 1
Summary of thermodynamic and kinetic parameters of the RhoGDI interaction with GDP- and GMPPNP-associated RhoA
Protein kon koff Kd
M1 s1 s1 M
RhoAGDP 2.42
 0.15 0.54
 0.01 0.17 106
RhoAGMPPNP 3.8
 1.9 8.77
 0.73 2.5 106
CFP-RhoAGDP-GG 37a (2.0
 0.02) 104 (5.4
 2.5) 1012
CFP-RhoAGMPPNP-GG 1.6a (4.6
 0.03) 103 (2.9
 0.65) 109
RhoAGDP-GNBD 10.7
 0.7 (5.8
 0.3) 102 (2.0
 0.15) 109
RhoAGDP-F NDb ND (2.5
 1.1) 109
a Calculated from kon koff /Kd.
b ND, not determined.
Quantitative Analysis of RhoA Interaction with RhoGDI
26552 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 32•AUGUST 3, 2012
 at UQ Library on October 4, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
nificantly decrease the affinity (supplemental Fig. S1, A and B).
These data suggest that similar to the Rab GTPases, the C ter-
minus of theRhoA significantly contributes to the affinity of the
RhoGDIRho complex (36). The presence of a lysine- and argi-
nine-rich patch in the C terminus of other Rho GTPases sug-
gests that this is a generic feature that may be important for
RhoGDI-mediated membrane recycling of Rho GTPases,
because it is also involved in the interaction with negatively
charged lipids (22, 37).
Fluorescent Prenylated RhoA as a Sensor of RhoGDI/Rho
Interaction—To elucidate themechanismunderlying RhoGDI-
mediated delivery and extraction of Rho GTPases, it is impor-
tant to characterize RhoGDI interactions with prenylated Rho
proteins. Hence, we sought to develop a fluorescent sensor that
would report on the interaction of RhoGDI with prenylated
RhoGTPases. This is a challenging task, because prenylated
proteins display low water solubility, which largely precludes
their direct biophysical analysis. All previous experiments
relied on detergent-solubilized prenylated proteins, a situation
that is known to strongly change the properties of prenylated
proteins (41, 42). To alleviate this problem, we took advantage
of synthetic phosphoisoprenoids modified with the fluorescent
NBD group. These analogs of FPP and GGPP can transfer
fluorescent lipidmoieties onto proteins by protein prenyltrans-
ferases. These are less hydrophobic than the native lipids due to
the shorter isoprenoid chain (28) (Fig. 3A). We enzymatically
prenylated the RhoA protein using recombinant GGTase-I and
NBD-geranyl pyrophosphate as a lipid donor. The reaction
mixture was resolved on a size exclusion column, and the fluo-
rescently prenylated RhoAwas eluted at a position correspond-
ing to a 20-kDa monomer. The protein was homogeneous (Fig.
3B) and remained soluble in the absence of detergent, even at
concentrations above 10 mg/ml. ESI-MS analysis of the frac-
tions revealed that the majority of protein was modified with
geranyl-NBD (Fig. 3C). Purified RhoA-GNBD was also cor-
rectly folded, because it was able to form a stoichiometric com-
plex with RhoGDI, as determined by gel filtration analysis (sup-
plemental Fig. S2A).
Addition of saturating concentrations of RhoGDI to a solu-
tion of RhoA-GNBD resulted in an1.5-fold decrease in NBD
fluorescence that could be used for titration experiments (Fig.
3D). Fitting the data to a quadratic equation led to a Kd value of
2 nM (Fig. 3E). To confirm this affinity estimate by an indepen-
dent method and gain insight into the kinetics of the interaction,
we rapidly mixed both proteins in a stopped-flow apparatus.
The observed trace could be fitted using a single exponential
function (Fig. 3F). A linear fit of the observed first-order asso-
ciation rate constants at a range of concentrations allowed us to
determine a kon value of 10.7 106M1 s1 for this reaction. To
obtain the koff value for this interaction, we mixed 100 nM
FIGURE 2. Thermodynamic analysis of RhoGDI interaction with C-terminal-truncated RhoAmutants. A, the alignment of human RhoA, Cdc42, and Rac1
protein sequences. The prenylatable cysteine is highlighted in bold, the gray background represents conservative sequence of positively charged amino acid
residues, and the C-terminal -helix is underlined. The C-terminal truncation of RhoA are indicated by arrows at corresponding positions. Titration of 10 M
solution of wild-type RhoA (B) or RhoA with a C-terminal deletion of 13 residues (C) with RhoGDI.
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RhoGDIRho-GNBD complex with 1 M farnesylated RhoA.
This resulted in a time-dependent increase in fluorescence,
reflecting dissociation of RhoGDIRhoA-GNBD and formation
of the RhoGDIRho-F complex. The fit of the data resulted in a
dissociation rate constant of 0.06 s1 (supplemental Fig. S2B).
From the obtained kinetic parameters, we calculated aKd value
of 5.6 nM, which is in good agreement with the equilibrium
titration experiments. These data demonstrate that RhoA-
GNBD binds to RhoGDI with an affinity higher than that cor-
responding toKd of 7, 30, or 180 nM, respectively, estimated for
RhoGDI interactions with the native geranylgeranylated Rho
proteinCdc42 (15, 16, 38). Taken together, these results suggest
that NBD-G mimics the native isoprenoid and that the devel-
oped sensor can be used to analyze RhoA/RhoGDI interactions.
Interaction of Farnesylated RhoA with RhoGDI—Several Rho
proteins can exist in both farnesylated and geranylgeranylated
forms in vivo (39–41, 45, 46). Thus, it is expected that RhoGDI
will govern the interaction of both prenylated formswithmem-
branes, but the biophysical parameters may differ significantly.
To analyze the interaction of farnesylated RhoA with RhoGDI,
we generated the RhoAL193A mutant, which is a more efficient
FTase substrate than wild-type of RhoA. The protein was in
vitro farnesylated by recombinant mammalian FTase and puri-
fied by gel filtration (supplemental Fig. S3). As expected, farne-
sylated RhoAL193A (RhoA-F) was soluble at concentrations
above 1 mg/ml. To determine the affinity of RhoA-F for
RhoGDI, we titrated 100 nM RhoA-GNBDwith increasing con-
centrations of RhoGDI in the presence of 50, 100, 200, or 400
nM GDP bound RhoA-F (Fig. 4A). The titration curves showed
an initial “lag” that was most prominent at high concentrations
of RhoA-F. This suggests that RhoGDI preferentially forms a
complex with the fluorescently silent RhoA-F. Data analysis
was performed via least square fitting using a 3-component
competitive model (42). The fit to the data shown in Fig. 4A
yielded a Kd value of 2.5 nM for the RhoGDI interaction with
farnesylated RhoA. These data suggest that farnesylated RhoA
has the capacity to form a tight complex with RhoGDI in
vivo.
Preparation of Solution-stabilized Geranylgeranylated RhoA
and Analysis of Its Interaction with RhoGDI—The data de-
scribed above demonstrate that prenylation of RhoA signifi-
cantly increases its affinity for RhoGDI. However, so far, it is
unclear to what extent an increase in the length of the isopre-
noid chain would influence the strengths of this interaction.
This is particularly important because Rho proteins are pre-
dominantly geranylgeranylated. In contrast to RhoA-GNBD
and farnesylatedRhoA, geranylgeranylatedRhoA is insoluble in
water and rapidly aggregates. To overcome this problem, we
took advantage of the observation that prenyltransferases form
stable complexes with their reaction products in the absence of
and excess of lipid donor (43). Hence, we geranylgeranylated
RhoA in vitro with recombinant GGTase-I using stoichiomet-
ric amounts of both proteins and purified the resulting complex
by size exclusion chromatography. The proteins coeluted as a
stoichiometric complex at a position corresponding to amolec-
ular mass of 160 kDa (Fig. 4B). MALDI-MS analysis demon-
strated that the majority of RhoA in the complex was gera-
nylgeranylated (Fig. 4C). The availability of solubilized
FIGURE 3. Construction and analysis of prenylated fluorescent RhoA sensor. A, chemical structure of NBD-GPP in comparison with structures of FPP and
GGPP.B,SDS-PAGEanalysis of RhoA-GNBDeluted fromSuperdex200 size exclusion column. Theupper panel showsagel stainedwithCoomassieBlue,whereas
the lower panel shows a fluorescent scan of the same gel (excitation laser, 473 nm; cutoff filter, 510 nm). C, ESI-MS analysis of RhoA-GNBD.D, emission spectra
of 50 nM solution of RhoA-GNBD before or after addition of 1M RhoGDI or GGTase-I. E, titration of RhoGDI to 50 nM solution of RhoA-GNBD. The fluorescence
of theNBDgroupwas excited at 479 nm, and the emissionwas collected at 560 nM. The Kd value of 2 nMwas calculatedby fitting data to the quadratic equation
using Grafit 5.0. F, kinetic analysis of RhoGDI interactionwith the RhoA-GNBD. The graph represents a typical time course of fluorescence signal changes upon
rapid mixing of 100 nM RhoA-GNBD and 1.5 M RhoGDI at 25 °C. The solid curve shows the single-exponential fit to the data. The inset represents a plot of the
observed pseudo-first order rate constant kobs versus concentration of RhoGDI.
Quantitative Analysis of RhoA Interaction with RhoGDI
26554 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 32•AUGUST 3, 2012
 at UQ Library on October 4, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
RhoA-GG enabled us to measure the affinity of the RhoGDI
interaction with RhoA-GG using RhoA-GNBD as a fluorescent
reporter. In this experiment, we titrated RhoGDI to a mixture
of 50 nM RhoA-GNBD with 100, 200, or 400 nM of the RhoA-
GGGGTase-I complex. As depicted in Fig. 4D, the titration
resulted in an initial increase of fluorescence, followed by its
quenching. This can be interpreted as the initial displacement
of GGTase-I from the RhoA-GG complex by RhoGDI and the
association of GGTase-I with RhoA-GNBD. At higher concen-
trations, however, all RhoA-GNBD became sequestered by
RhoGDI, leading to a signal decrease. We confirmed this by
analyzing the interaction of GGTase-I with RhoA-GNBD (sup-
plemental Fig. S4). The availability of the affinity values for the
RhoGDI and GGTase-I interactions with RhoA-GNBD and the
corresponding fluorescence yields prompted us to attempt to
extract the affinity for theRhoA-GGinteractionwithRhoGDIand
GGTase-I from these data. This is a challenging task because it
requires a quantitative description of a 4-component systemwith
2 setsof competitive interactions, i.e. RhoA-GNBDRhoGDIN
RhoA-GNBDRhoGDI and RhoA-GNBD  GGTase I N
RhoA-GNBDGGTase I, and RhoA-GG  RhoGDIN RhoA-
GGRhoGDI and RhoA-GGGGTaseIN RhoA-GGGGTase
I, related to each other in a nonlinear fashion. Implementing a
recursive least square minimization in Dynafit (Biokin Ltd.)
(34) allowed us to calculate the Kd values for the interactions of
native prenylated RhoA with RhoGDI and GGTase I. The fit-
FIGURE 4. Interaction analysis of prenylated RhoAGDPwith RhoGDI. A, titration of the RhoGDI into amixture of fluorescently labeled 100 nM RhoA-GNBD
(ex/em 479/560 nm) in the absence (open diamonds) and presence of increasing concentrations of RhoA-F: 50 (open circles), 100 (filled circles), 200 (open
squares), and 400 nM (filled squares). The data were fitted to a competitive model, resulting in a Kd value of 2.5 nM. B, purification of the RhoA-GGGGTase-I
complex by size exclusion chromatography and SDS-PAGE analysis of complex containing fractions. Arrows indicate elution volumes of molecular weight
standards. C, theMALDI-MS analysis of the purified RhoA-GGGGTase-I complex.D, titration of RhoGDI to a 15 nM solution of RhoA-GNBD in the absence (open
triangles) or presence of 100 (open circles), 200 (filled circles), or 400 nM (open squares) RhoA-GGGGTase-I complex. The data were fitted globally by numerical
simulation to a competitive binding model in the program Dynafit 4.0.
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ting procedure consistently gave us differences of 3 orders of
magnitude in the affinities of RhoA-GG/GGTase I and RhoA-
GG/RhoGDI interactions, the values of which are 5.4
 2.5 nM
and 5.6
 4.5 pM, respectively.
The affinity for the RhoA-GG/RhoGDI interaction was
unexpectedly high, particularly in the view that RabGDI inter-
acts with GDP-bound diprenylated Rab proteins with an affin-
ity nearly 500 times lower (9). Thus, we sought to confirm the
RhoA-GG/RhoGDI dissociation constant value by an inde-
pendent and more direct method. We decided to use fluores-
cence cross-correlation spectroscopy (FCCS), because it allows
direct monitoring of interacting molecules at very low concen-
trations. To this end, we genetically fused the RhoAN terminus
withCFP and produced the proteins in pure recombinant form.
We then took advantage of the fact that RhoGDI contains only
one solution-exposed cysteine residue (Cys-79) that is located
on the loop after -strand A and that is not involved in interac-
tion with Rho GTPases. Thus modification of this residue does
not affect its associationwith RhoA (38).We chemically labeled
RhoGDI with tetramethylrhodamine-maleimide (RhoGDI-
TMR). The complex of RhoGDI-TMRwith geranylgeranylated
GDP-bound CFP-RhoA was formed by mixing both compo-
nents and purifying the resulting complex by gel filtration (sup-
plemental Fig. S5). As a measure of CFP-RhoA-GGRhoGDI-
TMR complex concentration in the FCCS analysis, we used the
cross-correlation function (CCF) (44). We observed a decrease
in the CCF value upon addition of farnesylated RhoA, which
indicates competitive formation of the RhoGDIRhoA-F com-
plex. Fitting the competitive titration curve of the CFP-RhoA-
GGRhoGDI-TMR fluorescent complex with RhoA-F using a
3-component competitivemodel led to aKd value of 20 pM (Fig.
5A). This provides direct and independent confirmation of the
FIGURE 5. Interaction analysis of prenylated RhoA interactionwith RhoGDI. A, competitive displacement of the CFP-RhoAGDP-GGRhoGDI-TMR complex
by farnesylated RhoA observed by FCCS.Open circles correspond to the value of the cross-correlation function at the indicated concentrations of RhoA-F. Solid
line is the fit of experimental data to a competitive binding model, leading to a Kd value of 21 pM. Bars represent S.D. from two independent measurements.
B, titration of RhoGDI into the 25 nM solution of RhoA-GNBD in the absence (filled circles) or presence of 100 (open circles), 200 (filled triangles), or 400 (open
triangles), and 600 nM (filled diamonds) of the RhoAGMPPNP-GGGGTase-I complex. The data were fitted globally by numerical simulation to a competitive
binding model in the program Dynafit 4.0. The Kd values obtained for the RhoA-GG/GGTase-I interaction is12 nM, and for RhoA-GG/GMPPNP/RhoGDI, the
affinity is2.9 nM. C, kinetics of dissociation of the CFP-RhoA-GGRhoGDI-citrine complex, measured by the changes in FRET efficiency (ex 436 nm/em,DONOR
470 nm, andem,ACCEPTOR 530 nm). In the experiment, 30 nMCFP-RhoAwas displaced from the complex by the addition of 2M farnesylated RhoA. Purple curve
corresponds to a EFRET change upon dissociation of CFP-RhoAGDP-GGRhoGDI-citrine complex, whereas red represents the change in EFRET of dissociating
CFP-RhoAGMPPNP-GGRhoGDI-citrine. Blue and green curves are EFRET of corresponding complexes alone. Black solid lines are fits to a single exponential
functionwith offset.D, represents titration of CFP-RhoAGDP-GGRhoGDI-citrine complexwith farnesylated RhoA. The fit of experimental data led to a Kd of the
CFP-RhoAGDP-GG interaction with RhoGDI of 16 pM.
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low picomolar affinity of RhoGDI to geranylgeranylated RhoA.
Interaction of Activated Geranylgeranylated RhoA with
RhoGDI—The current model of GTPase action postulates that
GTPases are activated uponmembrane delivery and recycled to
the cytosol following completion of the functional cycle,
marked by GTP hydrolysis. However, several reports suggest
that RhoGDI can also efficiently interact with GTP-loaded Rho
proteins (10, 11, 15, 16) and promote their release from the
intracellular membranes (45, 46). We therefore measured the
affinity of RhoGDI for the activated form of prenylated RhoA.
We prepared the GMPPNP-bound form of geranylgeranylated
RhoA using the approach described for the production of the
GDP-bound form of RhoA-GG. We then titrated RhoGDI to a
mixture of 25 nM RhoA-GNBDwith 100, 200, 400, or 600 nM of
the RhoAGMPPNP-GGRhoGDI complex (Fig. 5B). Global fit
of the titration data resulted in aKd value of 3 nM for the RhoA/
GMPPNP-GG/RhoGDI interaction, whereas the affinity of
RhoA-GG interaction with GGTase-I was slightly lower for the
GMPPNP-bound formof RhoA, with aKd value of 12 nM. Thus,
RhoGDI displays a 500-fold difference in affinity between the
GDP- and GTP-bound forms of geranylgeranylated RhoA. Our
data demonstrate that similar to RabGTPases, the nucleotide-
bound state of RhoA dramatically affects its affinity for its GDI.
Although the discrimination factor is somewhat less than in the
Rab/RabGDI interaction (about 2  103), it is still large and
likely to play an important biological role. The fact that affini-
ties for both forms are so high provides an explanation for pre-
vious confusion in the field, because most of the biochemical
methods of protein interaction analysis cannot distinguish
between low nanomolar and picomolar affinities.
Analysis of Dissociation Rates of RhoGDIRhoA-GG
Complexes—The postulated biological role of RhoGDI is to
sequester the Rho proteins in the cytosol and to transport them
to a target membrane. Although the exact time scale of this
process is unknown, it is expected to be on the order ofminutes
(47). This would require Rho-GGRhoGDI complexes to have
reasonably fast intrinsic or induced off-rates (102 to 103 s1).
This notion promoted us to determine the dissociation rates of
the RhoA-GGRhoGDI complex experimentally, because the
determined low picomolar affinity for RhoAGDP containing-
and low-nanomolar affinity for RhoAGMPPNP-containing
complexes is most likely to reflect their slow off-rate. Unfortu-
nately, the developed 4-component system, based on RhoA-
GNBD, is not suitable for kinetic measurements due to a large
number of unknownkinetic parameters. Thus,we developed an
alternative sensor in which the fluorescence resonance energy
transfer occurs from a CFP domain that is fused to the N ter-
minus of RhoA to the citrine domain that is fusedC-terminal to
RhoGDI (supplemental Fig. S6A). ITC analysis showed that
the unprenylated CFP-RhoARhoGDI-citrine complex has an
affinity only 3 times lower than the native RhoARhoGDI com-
plex (supplemental Fig. S6B). Moreover, a competitive titration
of the CFP-RhoA-GGRhoGDI-citrine complex with farnesy-
lated RhoA resulted in a Kd value of 16
 5 pM (Fig. 5C, inset),
indicating that it behaves similarly to the native complex. The
dissociation rate was measured by mixing 30 nM of complexes
containing either GDP- or GMPPNP-associated RhoA with 5
M farnesylated RhoA andmonitoring the change in FRET effi-
ciency (Fig. 5C and supplemental Fig. S6, E and F). As can be
seen in Fig. 5C, both the CFP-RhoAGDP-GGRhoGDI-citrine
and CFP-RhoAGMPPNP-GGRhoGDI-citrine complexes are
very stable, but the addition of excess of RhoA-F led to their
dissociation, which is reflected in the decay of FRET efficiency.
Remarkably, the extremely slow dissociation rate of the CFP-
RhoAGDP-containing complex (2 104 s1) is increased by
a factor of only 25 (Table 1), meaning that the half-life of the
CFP-RhoAGMPPNP-GGRhoGDI-citrine complex is 2.5 min.
This relatively modest decrease in the half-life of the complex
despite almost 3 orders of magnitude change in the affinity on
replacing GDP by GMPPNP means that the association rate
constants for the complexes also differ by a factor of about 25
(Table 1). The rate constant for the dissociation of CFP-
RhoAGDP-containing complex (2 104 s1)means that 50%
dissociation will take about 1 h, which is probably too slow to
allow the complex to operate in cellular systems that require
responses on a time scale of minutes.
Crystal Structure of the RhoAGMPPNP-GGRhoGDI
Complex—To gain insight into the molecular basis of
RhoAGTP recognition by RhoGDI, we attempted a structural
analysis of the activated form of the complex. Using the in vitro
prenylation approach described above, we generated prepara-
tive amounts of the RhoAGMPPNP-GGRhoGDI complex and
subjected it to crystallization trials and diffraction testing, as
described under ”Materials andMethods.“ The best diffracting
crystal was used to collect the dataset to 2.8 Å using a synchro-
tron beam source. The structure was solved by molecular
TABLE 2
Data collection statistics for the structure of geranylgeranylated
RhoAGMPPNP-GGRhoGDI complex
Data collection RhoAGPPNHP-GGRhoGDI
Wavelength (Å)/beamline 0.9537/AS-MXII
Resolution (highest shell, Å) 68.0–2.8 (2.9–2.8)
Space group P212121
Cell constants (Å; °) a 46.0, b 71.6, c 136.0;
   90
VM
Total measurements 56,189
Unique reflections 20,741
Average redundancy 2.7 (2.7)
I/	 12.3 (3.6)
Completeness (%) 97.0 (98.1)
Rsyma 6.9 (26.5)
Wilson B-factor (Å2) 41.7
Refinement 2.8
Resolution (highest shell, Å) 2.8 (2.87–2.8)
Rb 20.6 (20.7)
Rfreec 28.1 (32.5)
Root mean square deviation bonds
(Å)/angles (°)
0.015/1.743
B-factor deviation
Bonds/angles (Å2)
Main chain 0.716/1.415
Side chain 2.095/3.696
Residues in ramachandran core (%)d 92.0
Protein atoms 2997
Solvent atoms 80
Ligand atoms 54
Average B-factor (Å2) 32.7
PDB accession code
aRsym  I(h)j I(h)/I(h)j, where I(h)j is the measured diffraction inten-
sity, and the summation includes all observations.
b R is the R-factor (Fo  Fc)/Fo.
c Rfree is the R-factor calculated using 5% of the data that were excluded from the
refinement.
d Ramachandran core refers to the most favored regions in the 
/-Ramachan-
dran plot, as defined by Laskowski et al. (61).
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replacement using the Cdc42GDP-GGRhoGDI structure as a
searchmodel (48). Full data collection and refinement statistics
are given in Table 2. The overall structure of the complex is
shown in Fig. 6A. The structure is remarkably similar to the
structure of the Cdc42GDP-GGRhoGDI complex (PDB
1DOA), with an overall root mean square deviation on the
-chain of 0.87 Å.
Total interface area in the RhoAGMPPNP-GGRhoGDI
complex excluding geranylgeranylRhoGDI hydrophobic pocket
interface is somewhat smaller than in the structure of Cdc42
GDP-GGRhoGDI complex (1340 versus 1580Å2) with a signif-
icantly lower number of hydrogen bonds and salt bridges form-
ing the RhoAGMPPNP-GGRhoGDI complex. These differ-
ences predominantly come from extensive interaction of
RhoGDI with residues Arg-186 and Arg-187 of Cdc42. The C
terminus of RhoA does not have a diarginine patch, instead
there are 3 lysine residues that do not form hydrogen bonds
with RhoGDI and are solely involved in the electrostatic
interaction.
The position of geranylgeranylmoiety buried into the hydro-
phobic pocket on the RhoGDI is nearly identical to what is
identified on the structure of Cdc42-GGGDPRhoGDI. The
minor differences such as involvement of RhoGDILeu-170 in
interaction with the RhoA geranylgeranyl group are unlikely to
be functionally significant. Despite the differences in the inter-
face of RhoGDI complexes with RhoA and Cdc42 the total free
binding energy calculated by PISA (35) is similar for both com-
plexes: 25.6 kJ/M for RhoARhoGDI and 27.4 kJ/M for
Cdc42RhoGDI.
The Rho-specific helix in the RhoAGDP-GGRhoGDI struc-
ture has different conformations than both in the free form of
Cdc42 and in the Cdc42 complex with RhoGDI. In contrast to
the Cdc42 the Rho insert in the structures of free RhoA and in
complex with RhoGDI has an almost identical position. This
might reflect differences in the signaling modes of the RhoA
and Cdc42 GTPases in the cell (49).
Strikingly, the switch I and II loops of RhoAGMPPNP adopt
a nearly identical conformation to those of Cdc42GDP in com-
plex with RhoGDI. As can be seen in Fig. 6C, the conformations
of both switch I and switch II regions in the complex differ
markedly from the conformations observed in unliganded
RhoAGMPPNP. Although switch I adopts a conformation
nearly identical to that of GDP-bound RhoA, the switch II
region adopts a conformation distinct from both free forms,
due to the extensive contacts formed with the N terminus of
RhoGDI. The phosphate groups of the bound nucleotide are
shifted slightly toward the exterior of the protein, possibly
reflecting the fit induced by the complex formation.Overall, the
FIGURE 6.Structureof RhoAGMPPNP-GGRhoGDI complex (PDB4F38).A, overall structure of the complex. RhoGDI is displayed as agraymolecular surface,
whereas RhoA is displayed in ribbon representation. The nucleotide and the conjugated geranylgeranyl isoprenoid are displayed in ball-and-stick represen-
tation. The Mg2 is displayed as a space-filling magenta ball. B, 2.5 	 (Fo  Fc) difference in electron density of the bound GMPPNP and geranylgeranylated
cysteine at the RhoA C terminus before incorporation into the model. C, superimposition of the prenylated CDC42GDP and RhoAGPPNHP complexed with
RhoGDI. D, as in C but RhoAGMPPNP complexed with RhoGDI is superimposed with unbound GMPPNP-associated (red) and GDP-associated (blue) forms of
RhoA.
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guanine nucleotide in the structure of RhoAGMPPNP-
GGRhoGDI has a 15% smaller interaction interface and less
number of hydrogen bonds than in the structure of
RhoAG14VGTPS alone (50). For instance, there is no interac-
tion between phosphate oxygen atoms and Ala-15 from the
P-loop, switch I residues Tyr-34 and Thr-37 are no longer
involved in nucleotide -phosphate positioning. Interestingly,
important for GTP hydrolysis, the Gln-63 residue in the
RhoAGMPPNP-GGRhoGDI structure is located closer than
in RhoAG14VGTPS, which results in hydrogen bond forma-
tion between its amide group and the oxygen of -phosphate
with an overall distance of 3.84 Å.
The observed structure demonstrates that even in the GTP-
bound form, the loop regions of RhoGTPases are sufficiently
flexible to adopt an inactive conformation upon binding to
RhoGDI. The resulting conformational strain can be compen-
sated by the very high binding energy of the complex formation
and results in a complex that is structurally identical to the
inactive conformation but displays a faster dissociation rate.
DISCUSSION
In the present study, we have performed a comprehensive
analysis of the interaction of RhoGDI with prenylated and
unprenylated forms of RhoA using kinetic and thermodynamic
measurements.We have focused on the role of prenylation and
the nucleotide-bound state on complex formation and its
implications for recycling RhoGTPases.
We constructed a sensor of the RhoGDI/RhoGTPase inter-
action by in vitro prenylation of RhoA with the NBD-deriva-
tized fluorescent isoprenoid. The developed enzymatic route is
significantly simpler than the previously described semisynthe-
sis-based approach for construction of fluorescent lipidated
proteins (51) and can be easily extended to other GTPases.
Using the developed sensor, we were able to determine the
affinities of geranylgeranylated and farnesylated RhoA for
RhoGDI. The affinities for RhoA-GG/RhoGDI interactions
were much higher than previously reported (16), with RhoGDI
binding to GDP-bound geranylgeranylated RhoA with a Kd
value of 5 pM. We demonstrated that the length of the isopre-
noid chain has a dramatic impact on the RhoA interaction with
RhoGDI. The affinity difference of nearly 3 orders ofmagnitude
between farnesylated and geranylgeranylated complexes indi-
cates that farnesylated and geranylgeranylated Rho proteins
will be regulated quite differently by RhoGDI in vivo. Clearly, in
the absence of a large pool of free RhoGDI, farnesylated Rhos
will be outcompeted by the geranylgeranylated form and there-
fore are likely to distribute through alternative mechanisms.
We also demonstrate that activation of RhoA results in a 500-
fold decrease in the affinity of the complex. The high affinity of
RhoGDI complexes with bothGDP- andGMPPNP-bound pre-
nylated RhoA molecules implies their slow dissociation rates,
which we found to be 104 and 102 s1, respectively. These
results have revealed that the RhoAGDP-GGRhoGDI com-
plex is very tight and has a half-life of60 min. In contrast, the
half-life of theGMPPNP-loadedRhoA-GGRhoGDI complex is
only 2.5 min, which fits better into the physiological context
(47) and suggests the presence of two types of RhoGDIRhoA
Scheme 1.Mechanism of RhoA extraction by RhoGDI.
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complexes in vivo with dramatically different half-lives.
These findings further support the idea that RhoGDI is
actively involved in the recycling and distribution of acti-
vated RhoGTPases in the cell (52, 53). To gain insight into the
mechanismunderlying the ability of RhoGDI to stably associate
with the activated form of RhoA, we solved the structure of the
activated form of the complex and demonstrated that complex
formation induces adoption of the inactive conformation with-
out nucleotide hydrolysis. Formation of an extensive set of con-
tacts between RhoGDI and switch II partially through hydro-
phobic interaction with Leu-67 and Leu-70 of RhoA stabilizes
the loop and, importantly, secures the essential GTP-hydrolysis
Gln-63 residue, which results in inhibition of GTPase hydro-
lytic activity (11). The nucleotide independence of the confor-
mation of switch II, which forms the second largest interface in
the RhoAGMPPNP-GGRhoGDI complex, most likely pro-
motes association of the proteins, which involves energetically
unfavorable changes in the switch I region. Notably, the role of
switch II in the recognition of both nucleotide-bound forms of
RhoGTPases by RhoGDI was suggested earlier (48). The struc-
tural transition of the switch I loop occurs at the cost of inter-
action the free energy, which is reflected by a difference of
almost 3 orders of magnitude in affinities for RhoA-GG
RhoGDI complexes (Table 1). The association of RhoGDI with
activated RhoA in solution is 25 times slower thanwith inactive
RhoA, because it requires a structural transformation of the
latter molecule. Additionally, the dissociation rate of such a
complex is faster by almost the same factor, due to the strain in
switches I and II. The ITC data, furthermore, demonstrate
that the binding enthalpy of RhoGDI to unprenylated
RhoAGMPPNP is 2-fold lower than the enthalpy of the
RhoGDI interaction with the GDP-bound RhoA protein. Com-
parison of the structures of the Cdc42GDP-GGRhoGDI and
RhoAGMPPNP-GGRhoGDI complexes indicates the lack of
major changes in the interaction surface area. Thus, change in
the binding enthalpy most likely reflects the free energy cost of
the conformational change in the switch I loop that is required
for RhoAGMPPNPRhoGDI complex formation.
The results obtained in this work, in combination with data
from previous biochemical and crystallographic studies, allow
us to formulate a detailed mechanistic model of the RhoGDI-
mediated recycling of prenylated RhoGTPases in vivo. Our
analysis of the interaction of unprenylated RhoA with RhoGDI
provides insight into the initial stages of RhoA extraction from
the membranes, because the isoprenoid moiety is embedded
into themembrane and unlikely to contribute to the interaction
at this stage. It is likely that RhoGDI initially forms a micromo-
lar-affinity complexwith RhoAby recognizing the switch II and
I regions but not the C terminus. Next, the positively charged C
terminus of RhoA binds to the negatively charged residues
in the C-terminal RhoGDI domain. This increases the
RhoARhoGDI complex residence time on the membrane and
allows progression to the next step in extraction, in which the
isoprenoid group spontaneously flips out of the membrane and
is captured by the lipid-binding pocket of RhoGDI. This even-
tually triggers release of the complex from the membrane
(Scheme 1). In general, RhoGDI and RabGDI appear to operate
in a similar way in extracting the respective GTPases from
membranes, using sequential formation of progressively tighter
complexes that function as a thermodynamic trap. However,
the quantitative data suggest that Rho and RabGDI operate dif-
ferently in the sense that the former distributes both nucle-
otide-bound forms between membranes and cytosol, whereas
the latter acts only on inactive conformations, albeit with quan-
titative differences. Given the exceptionally high affinities of
RhoGDI complexes with prenylated RhoA of both nucleotide-
bound forms, the local concentration of RhoGDI in the cell will
govern the extraction process of GDP- and GTP-bound Rho
proteins. Low and limiting RhoGDI concentrations will mostly
lead to the extraction of GDP-associated Rho proteins that will
outcompete short-lived and weak RhoAGTPRhoGDI com-
plexes. In contrast, a local abundance of RhoGDI will result in
extraction of both inactive and activated RhoGTPases. The
transient RhoGDI association with GTP-bound Rhomolecules
will favor its local distribution. The presence of slow and fast
cycling pools of the RhoGTPase cycle in the cell was proposed
earlier (27, 53, 54). The mechanism of dissociation of these
complexes is unclear at present and, according to our data,
cannot be based solely on nucleotide exchange. Therefore,
unlike the case of RabGTPases, where GEFs have been sug-
gested to be sufficient to drive targeted membrane insertion of
Rabs, it seems likely that dissociation of RhoGDIRhoGTPase
complexes must be further accelerated by other factors.
Recently demonstrated Arl-GTP-mediated displacement of
farnesylated Rheb from its GDI-like chaperon PDE provides
an example of a possible mechanism (60). Alternative factors
may include some types of lipids and phosphorylation of both
Rho and RhoGDI. Therefore, further research is needed in this
area to fully understand the role of RhoGDI in the membrane
targeting and recycling of RhoGTPases in the cell.
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Figure S1. Thermodynamic analysis of RhoGDI interaction with C-terminally truncated RhoA mutants: 
(A) 200 M RhoGDI was titrated into a 10 M solution of RhoA with a deletion of 13 residues. Graph 
(B) depicts derived affinities (Kd) of RhoGDI:RhoA interactions. 
  
  
 
 
 
Figure S2. (A) Interaction of the RhoA-GNBD with RhoGDI, as is determined by size-exclusion 
chromatography. The graph represents the profile of size-exclusion chromatography on Superdex 200 
(10/30). The dashed line is the chromatogram of the prenylation mix (RhoA, GGTase-I and NBDGPP); 
the solid line is the chromatogram of the same mix after the addition of RhoGDI equimolar to RhoA. (B) 
Kinetics of dissociation of the 0.1 M RhoGDI:RhoA-GNBD complex. Dissociation of the complex was 
triggered by addition of 10-fold excess of farnesylated RhoA. 
  
 
Figure S3. Purification of the farnesylated RhoA. (A) Characterization of farnesylated RhoA by size-
exclusion chromatography on Superdex 200 10/30. Arrows correspond to the elution volumes of gel-
filtration protein standards (Bio-Rad). Embedded picture shows the SDS/PAGE gel of the relevant 
fractions stained with Coomassie Blue. Next pane (B) shows ESI-MS spectrum of the RhoA-F solution. 
  
 
Figure S4. Interaction analysis of GGTase-I interaction with RhoA-GNBD. Titration of GGTase-I into 
the 50 nM solution of RhoA-GNBD (ex/em 479/560 nm). The fit to a quadratic equation resulted in a Kd 
value of 583 nM. 
  
 
 
Figure S5. Purification of the complex of geranylgeranylated CFP-RhoA with RhoGDI labeled with 
tetramethylrhodamine. The graph show the elution profile of the CFP-RhoA-GG:RhoGDI-TMR complex 
from Superdex 75 10/30. Upper pane is the SDS/PAGE of the relevant fraction illuminated with UV; the 
lower pane show the same gel stained with Safe Blue (Invitrogen).  
 
Figure S6. Construction of a FRET sensor of RhoGDI:RhoA interaction. (A) Spectra of 0.5 M CFP-
RhoA (black line), 0.5 M CFP-RhoA in the presence of 0.5 M RhoGDI-Citrine (green line), and after 
addition of 10 M RhoA wt to this mixture (red line). Samples were excited at 440 nm. (B) ITC analysis 
of RhoGDI-Citrine interaction with GDP-bound CFP-RhoA; 34 M CFP-RhoA was titrated with 470 M 
RhoGDI-Citrine. Fit of the obtained curve led to a Kd value of 430 nM. (C) Purification of the RhoGDI-
Citrine complex with geranylgeranylated GDP-bound CFP-RhoA on Superdex 200 (10/30). Upper pane 
depicts elution profile; the lower pane is SDS/PAGE of the fractions stained with Safe Blue (Invitrogen). 
Enclosed dashed box indicates fractions collected for further experiments. (D) As in (C) except that the 
complex between the GMPPNP-bound geranylgeranylated CFP-RhoA with RhoGDI was purified. (E) 
Time course of CFP and Citrine fluorescence change upon addition of 2 M RhoA-F to the 30 nM CFP-
RhoA:GMPPNP-GG:RhoGDI-Citrine complex. (F) Same as in (E) except that the complex contained 
geranylgeranylated CFP-RhoA:GDP. 
 
 
Kirill Alexandrov
Abankwa, Anouk Stigter, Brett M. Collins, Herbert Waldmann, Roger S. Goody and 
Zakir Tnimov, Zhong Guo, Yann Gambin, Uyen T. T. Nguyen, Yao-Wen Wu, Daniel
RhoGDI
Quantitative Analysis of Prenylated RhoA Interaction with Its Chaperone,
doi: 10.1074/jbc.M112.371294 originally published online May 24, 2012
2012, 287:26549-26562.J. Biol. Chem. 
  
 10.1074/jbc.M112.371294Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2012/05/24/M112.371294.DC1.html
  
 http://www.jbc.org/content/287/32/26549.full.html#ref-list-1
This article cites 59 references, 24 of which can be accessed free at
 at UQ Library on October 4, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
